Crypto
Why Ripple Will Not Continue with Plans for an IPO in the USA
Ripple (XRP) has decided against pursuing a US IPO due to the SEC’s “hostility” towards the crypto industry, as CEO Brad Garlinghouse explained. Ripple has been in a legal battle with the SEC over XRP’s classification as a security. Speculation suggests Ripple may consider an IPO outside the US, possibly in London or Tokyo.
Ripple (XRP) will not go ahead with a planned IPO in the USA. CEO Brad Garlinghouse referred to the SEC, which is hindering the crypto industry. Is London now coming into play?
For around five years, Ripple (XRP) has been thinking about an IPO with some regularity
CEO Brad Garlinghouse has repeatedly taken up the topic – and has now made a decision. According to “Good Morning Crypto,” Garlinghouse made a firm statement in a background discussion and said that Ripple is no longer interested in a US IPO. He cited the “hostility” that the US Securities and Exchange Commission (SEC) is demonstrating towards the crypto industry as the reason for this.
Garlinghouse recalled the example of Coinbase. The crypto exchange went public in April 2021 with the approval of the SEC – and is now being sued by the SEC for business details that were discussed before the IPO, said Garlinghouse. He can only advise entrepreneurs in the crypto industry not to implement their projects in the USA because they would have to expect costly legal proceedings there.
Ripple itself is at odds with the SEC and has been fighting in court for more than three years against the SEC’s attempt to classify XRP as a “securities”. Ripple has so far obtained two rulings in its favor, but currently has to fear that the SEC will file an appeal . This uncertainty also seems to be hindering the launch of a stablecoin planned by Ripple called RLUSD.
In general, Ripple is working on reforming itself into a financial services provider . The community is now speculating whether Ripple could attempt an IPO outside the USA. London is being mentioned. However, Ripple’s management has not commented on such considerations.
Conclusion: Is Ripple ready for the stock market? What will become of XRP?
A major investor in Ripple is the Japanese SBI Group , which is expecting an IPO. Against this background, a placement of Ripple shares on the Tokyo Stock Exchange, for example, would also be conceivable. Investors are meanwhile keeping an eye on the price development of XRP.
Despite the court successes, Ripple’s cryptocurrency is not developing its own momentum and has been oscillating in a relatively narrow corridor between 0.45 and 0.70 US dollars for years now. With the debut of the Ripple stablecoin RLUSD expected later in 2024, XRP is likely to continue to lose importance in the foreseeable future.
__
(Featured image by salesblog_at via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Markets1 week ago
Markets Surge on Trump Victory—But Can Overvaluation and Recession Risks Stall the Rally?
-
Biotech2 days ago
Sanofi Injects 40 Million Euros to Strengthen Its Production in France
-
Biotech1 week ago
Laminar Pharma Raises 5.9 Million in a New Round of Financing
-
Crypto2 hours ago
Bitcoin ETF Options Debut in the U.S.: Is a New All-Time High on the Horizon?